Carlisle Companies Incorporated (NYSE:CSL) is reinforcing its commitment to innovation through the development and execution of its new innovation accelerator program. The innovation accelerator program builds on Carlisle's track record of innovation success by engaging entrepreneurs and start-ups across the globe to identify, develop, and commercialize new products that deliver energy efficiency, labor savings and integrated solutions. Chris Koch, Chair, President and Chief Executive Officer, said, "As we stated in our Vision 2030 strategy, we are increasing investment in R&D to deliver new innovative products and solutions to our customers. Our innovation accelerator is just one of many

Carlisle Companies Incorporated (NYSE:CSL) today announced its fourth quarter 2024 financial results. Delivered record full year diluted EPS of $18.34 and adj. EPS of $20.20, a 30% YoY increase Fourth quarter revenue of $1.1 billion, declined 0.4% YoY Diluted EPS of $3.56 and record adj. EPS of $4.47 for the quarter, increased 7% YoY Operating margin of 19.9% and adj. EBITDA margin of 25.1% Completed the acquisition of Plasti-Fab, a Canadian based manufacturer of EPS insulation Repurchased $420 million of shares in Q4, totaling $1.6 billion of share repurchases in 2024 2025 outlook includes MSD revenue growth and ~50 bps of adj. EBITDA margin expansion Comments fro

Expanded executive team to support operational excellence and commercialization of the CellFX nanosecond PFA Platform Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3, 2025. "I am excited to announce Jon as our next CFO, further building upon our momentum at Pulse Biosciences. His experience as a financial leader at both growth stage and scaled public diversified medtech companies will be extremely valuable in our efforts to advance our nanosecon

Wolfe Research upgraded Axalta Coating Systems from Peer Perform to Outperform and set a new price target of $41.00

Citigroup downgraded Axalta Coating Systems from Buy to Neutral and set a new price target of $41.00 from $45.00 previously

KeyBanc Capital Markets downgraded Axalta Coating Systems from Overweight to Sector Weight

4 - Axalta Coating Systems Ltd. (0001616862) (Issuer)

4 - Axalta Coating Systems Ltd. (0001616862) (Issuer)

4 - Axalta Coating Systems Ltd. (0001616862) (Issuer)

10-K - CARLISLE COMPANIES INC (0000790051) (Filer)

10-K - Axalta Coating Systems Ltd. (0001616862) (Filer)

SCHEDULE 13G - Axalta Coating Systems Ltd. (0001616862) (Subject)

Expanded executive team to support operational excellence and commercialization of the CellFX nanosecond PFA Platform Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3, 2025. "I am excited to announce Jon as our next CFO, further building upon our momentum at Pulse Biosciences. His experience as a financial leader at both growth stage and scaled public diversified medtech companies will be extremely valuable in our efforts to advance our nanosecon

PHILADELPHIA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta" or the "Company"), a leading global coatings company, today announced that Tim Bowes has been appointed President, Global Industrial Coatings, effective January 27, 2025. Mr. Bowes will succeed Shelley Bausch who will be stepping down from her role. Most recently, Mr. Bowes served as Axalta's Senior Vice President and Chief Transformation Officer. Prior to joining Axalta, he served as Senior Vice President and President of Electrification, Industrial, Aftermarket, Purchasing & Supply Chain for Meritor. Mr. Bowes has also served as Senior Vice President and President of the Casting business un

CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement to sell PFB's Plasti-Fab and Insulspan business units to Carlisle Companies Incorporated (NYSE:CSL). The sale price for the business is approximately USD $260 million, and the transaction is expected to close in Q4 2024. Headquartered in Calgary, Alberta, PFB is a leading vertically integrated provider of Expanded Polystyrene (EPS)-based insulation products throughout North America. PFB's Plasti-Fab division operates eight man

Carlisle Companies Incorporated (NYSE:CSL) is reinforcing its commitment to innovation through the development and execution of its new innovation accelerator program. The innovation accelerator program builds on Carlisle's track record of innovation success by engaging entrepreneurs and start-ups across the globe to identify, develop, and commercialize new products that deliver energy efficiency, labor savings and integrated solutions. Chris Koch, Chair, President and Chief Executive Officer, said, "As we stated in our Vision 2030 strategy, we are increasing investment in R&D to deliver new innovative products and solutions to our customers. Our innovation accelerator is just one of many

Carlisle Companies Incorporated (NYSE:CSL) today announced its fourth quarter 2024 financial results. Delivered record full year diluted EPS of $18.34 and adj. EPS of $20.20, a 30% YoY increase Fourth quarter revenue of $1.1 billion, declined 0.4% YoY Diluted EPS of $3.56 and record adj. EPS of $4.47 for the quarter, increased 7% YoY Operating margin of 19.9% and adj. EBITDA margin of 25.1% Completed the acquisition of Plasti-Fab, a Canadian based manufacturer of EPS insulation Repurchased $420 million of shares in Q4, totaling $1.6 billion of share repurchases in 2024 2025 outlook includes MSD revenue growth and ~50 bps of adj. EBITDA margin expansion Comments fro

PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta"), a leading global coatings company, announced its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Highlights Record fourth quarter net sales of $1.3 billionNet income increased 85% year over year to $137 million, with net income margins of 10.5%, a year over year improvement of 480 basis pointsRecord fourth quarter Adjusted EBITDA of $275 millionAdjusted EBITDA margin improved 170 basis points year over yearDiluted EPS increased 91% to $0.63 and Adjusted Diluted EPS increased 30% to $0.60 Fiscal Year 2024 Highlights Record full year net

SC 13G - Axalta Coating Systems Ltd. (0001616862) (Subject)

SC 13G/A - Axalta Coating Systems Ltd. (0001616862) (Subject)

SC 13G/A - Axalta Coating Systems Ltd. (0001616862) (Subject)